We are live on ! Find out more
SRRA

Sierra Oncology, Inc. Common Stock
SRRA

Delisted

SRRA was delisted on the 30th of June, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of SRRA yet.

SRRA Hedge Fund Activity: Q4 2022 in Review

0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Sierra Oncology, Inc. Common Stock (SRRA) for Q4 2022, worth a combined $0 — down 100% from $4K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SRRA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Harbour Investments, exiting entirely with an estimated $4K sold.

  • 0 institutional investors held Sierra Oncology, Inc. Common Stock (SRRA) as of Q4 2022, down from 1 in Q3 2022.
  • Funds reported $0 of Sierra Oncology, Inc. Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Sierra Oncology, Inc. Common Stock positions in Q4 2022 and 1 closed out, a net change of -1 holder.
  • The largest Sierra Oncology, Inc. Common Stock seller in Q4 2022 was Harbour Investments, an estimated $4K sold.

Based on aggregated 13F filings for Q4 2022.